www.sgtreport.com
Anthropic is launching its own drug discovery programs for rare diseases using Claude superintelligence
by Lance D Johnson, Natural News: The news landed like a thunderclap in a San Francisco conference room on June 30, 2026. Anthropic, the artificial intelligence company behind the cutting-edge Claude model, announced it will launch its own preclinical drug-discovery programs targeting neglected diseases, including rare conditions, while simultaneously unveiling Claude Science, an AI workbench built […]